ArticleTobacco control2021
Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008-2017.
Article in Tobacco control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Beyond MPOWER: a systematic review of population-level factors that affect European tobacco smoking rates.European journal of public health · 2023Pooled it
- Projected preventable cancers through full implementation of tobacco control policies in East and South-East Asian countries, 2025-2050: a modeling study.The Lancet regional health. Western Pacific · 2026Article
- Use of Impulse Oscillometry in Patients with Chronic Obstructive Pulmonary Disease.Thoracic research and practice · 2026Article
- Why Prevention Needs More Than Individual Empowerment: Reclaiming Environmental Prevention.Journal of prevention (2022) · 2026Article
- Democracy, gender equality, advanced civil rights, economic welfare, and equitable distribution of wealth are related to the success of tobacco control.Tobacco induced diseases · 2026Article
- Using implementation science for WHO noncommunicable disease technical packages in low-and middle-income countries: a scoping review.Frontiers in health services · 2026Review
- Does raising tobacco taxes reduce the burden of non-communicable diseases? A panel data analysis of 152 countries.BMJ open · 2025Article
- Article
- Predictors of high tobacco use prevalence among adults in Autonomous Province of Vojvodina, Serbia.PloS one · 2025Article
- Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study.Frontiers in medicine · 2025Article
- Affordability of cigarettes in ten Southeastern European countries between 2008 and 2019.Tobacco control · 2024Article
- Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020.Globalization and health · 2024Article
- As countries improve their cigarette tax policy, cigarette consumption declines.Tobacco control · 2024Article
- How and why do financial incentives contribute to helping people stop smoking? A realist review.BMC public health · 2024Review
- Association between Tobacco Industry Interference Index (TIII) and MPOWER measures and adult daily smoking prevalence rate in 30 countries.Globalization and health · 2024Article
- A decade of tobacco control efforts: Implications for tobacco smoking prevalence in Eastern Mediterranean countries.PloS one · 2024Article
- Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United States.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2023Article
- Tobacco control policies implementation and future lung cancer incidence in Saudi Arabia. A population-based study.Preventive medicine reports · 2023Article
- Shifting the gaze on implementation: examining the association between the implementation of tobacco control laws and prevalence of tobacco using data from a nationally representative survey.BMC public health · 2023Article
- Use of Vaping as a Smoking Cessation Aid: A Review of Clinical Trials.Journal of multidisciplinary healthcare · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundWe revisited the association between progress in MPOWER implementation from 2008 to 2016 and smoking prevalence from 2009 to 2017 and offered an in-depth understanding of differential outcomes for various country groups.
methodsWe used data from six rounds of the WHO Reports on the Global Tobacco Epidemic and calculated a composite MPOWER Score for each country in each period. We categorised the countries in four initial conditions based on their tobacco control preparedness measured by MPOWER score in 2008 and smoking burden measured by age-adjusted adult daily smoking prevalence in 2006: (1) High MPOWER - high prevalence (HM-HP). (2) High MPOWER - low prevalence (HM-LP). (3) Low MPOWER - high prevalence (LM-HP). (4) Low MPOWER - low prevalence (LM-LP). We estimated the association of age-adjusted adult daily smoking prevalence with MPOWER Score and cigarette tax rates using two-way fixed-effects panel regression models including both year and country fixed effects.
resultsA unit increase of the MPOWER Score was associated with 0.39 and 0.50 percentage points decrease in adult daily smoking prevalence for HM-HP and HM-LP countries, respectively. When tax rate was controlled for separately from MPOWE, an increase in tax rate showed a negative association with daily smoking prevalence for HM-HP and LM-LP countries, while the MPOWE Score showed a negative association for all initial condition country groups except for LM-LP countries.
conclusionA decade after the introduction of the WHO MPOWER package, we observed that the countries with higher initial tobacco control preparedness and higher smoking burden were able to reduce the adult daily smoking prevalence significantly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.